LUPUS (BASINGSTOKE)
-
- Visão geral
-
- Metrics
-
- Identidade
-
- Ver todos
-
Visão geral
Qualis
código do país
tipo
publicação venue de
-
Cognitive dysfunction in patients with systemic lupus erythematosus. A cross-sectional study in a Brazilian sample.
1:096120332311767.
2023-01-01
-
Combined 13-valent pneumococcal conjugate and 23-valent pneumococcal polysaccharide vaccine regimens for adults with systemic lupus erythematosus: Does the sequence of pneumococcal vaccination affect immunogenicity responses? A single-center cohort study in Brazil.
32:096120332311535-703.
2023-01-01
-
Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: data from a multiethnic Latin American cohort.
32:658-667.
2023-01-01
-
Risk factors for mortality in 1528 Brazilian childhood-onset systemic lupus erythematosus patients.
1:096120332311705-1.
2023-01-01
-
A home-based exercise program during COVID-19 pandemic: Perceptions and acceptability of juvenile systemic lupus erythematosus and juvenile idiopathic arthritis adolescents..
31:443-456.
2022-01-01
-
Alexithymia in systemic lupus erythematosus: A cross sectional study in a Brazilian sample.
1:096120332211397.
2022-01-01
-
Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome.
1:096120332211017.
2022-01-01
-
Care provided by nurses to patients with juvenile systemic lupus erythematosus.
1:096120332210782.
2022-01-01
-
Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus.
31:1237-1244.
2022-01-01
-
CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome.
1:096120332210861-574.
2022-01-01
-
Development of an instrument to predict proliferative histological class in lupus nephritis based on clinical and laboratory data.
1:096120332211439-224.
2022-01-01
-
Efficacy of hydroxychloroquine in the prevention of thromboembolic events: A systematic review and meta-analysis.
01:096120332210741-245.
2022-01-01
-
Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register.
1:096120332211358-0.
2022-01-01
-
Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis.
31:97-104.
2022-01-01
-
Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: A possible mechanism for the reversal of atherosclerosis in the disease.
31:096120332210901-665.
2022-01-01
-
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.
1:096120332211020-1-8.
2022-01-01
-
Jaccoud-type lupus arthropathy.
31:398-406.
2022-01-01
-
MBL2 gene polymorphisms and its relation to infection in Brazilian systemic lupus erythematosus patients: A 10-years follow-up study.
31:279-286.
2022-01-01
-
Medication adherence in systemic lupus erythematosus during Brazilian COVID-19 pandemic.
01:096120332210741-0.
2022-01-01
-
Ocular findings in asymptomatic patients with primary antiphospholipid syndrome.
0(0):096120332211336-1807.
2022-01-01
-
Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort.
2:096120332211432-188.
2022-01-01
-
Selenium nutritional status and its association with SLEDAI-2K, HOMA-IR and lipid profile in Juvenile Systemic Lupus Erythematosus patients.
1:096120332110679-162.
2022-01-01
-
Social impact of disease parameters and damage accrual in adult Brazilian patients with childhood-onset Systemic Lupus Erythematosus.
31:944-952.
2022-01-01
-
Unchanged trend in mortality from systemic lupus erythematosus during the 2020 COVID-19 pandemic: A nationwide population-based study.
31:1020-1022.
2022-01-01
-
'PREMATURE RUPTURE OF MEMBRANES ? A CAUSE OF FETAL COMPLICATIONS AMONG LUPUS: A COHORT STUDY, SYSTEMATIC REVIEW AND META-ANALYSIS'.
30:1-12.
2021-01-01
-
10 Years of belimumab experience: What have we learnt?.
01:096120332110286.
2021-01-01
-
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome.
30:1314-1326.
2021-01-01
-
A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group.
1:096120332098858-640.
2021-01-01
-
Air pollution influence on serum inflammatory interleukins: A prospective study in childhood-onset systemic lupus erythematous patients.
30:2268-2275.
2021-01-01
-
Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic lupus erythematosus (SLE): What are the best-performing SLE classification criteria?.
11:1732-1738.
2021-01-01
-
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
1:096120332110625.
2021-01-01
-
Carriage prevalence, serotype distribution, and antimicrobial susceptibility among pneumococcal isolates recovered from adults with systemic lupus erythematosus.
-:096120332110305-1.
2021-01-01
-
Distinct features of youth-onset primary antiphospholipid syndrome.
00:096120332110380-1-8.
2021-01-01
-
Factors associated with neuropsychiatric involvement in Latin American patients with systemic lupus erythematosus.
30:1481-1491.
2021-01-01
-
Influenza A/Singapore (H3N2) component vaccine in systemic lupus erythematosus: A distinct pattern of immunogenicity.
00:096120332110403-1922.
2021-01-01
-
Infusion of anti-DFS70 antibodies prolonged survival of lupus-prone mice.
30:320-324.
2021-01-01
-
Laboratory-confirmed pediatric COVID-19 in patients with rheumatic diseases: A case series in a tertiary hospital.
30:856-860.
2021-01-01
-
MOG-IgG-associated disorder and systemic lupus erythematosus disease: Systematic review.
30:385-392.
2021-01-01
-
One-year prospective nerve conduction study of thalidomide neuropathy in lupus erythematosus: Incidence, coasting effect and drug plasma levels.
1:096120332199843-964.
2021-01-01
-
Reticular erythematous mucinosis: Literature review and case report of a 24-year-old patient with systemic erythematosus lupus.
30:325-335.
2021-01-01
-
Self-perceived quality of life of primary antiphospholipid syndrome patients using vitamin K antagonist.
1:096120332199007-714.
2021-01-01
-
Systemic lupus erythematosus in children and adults: A retrospective study in Brazilian patients.
1:096120332110103.
2021-01-01
-
The SLICC/ACR Damage Index (SDI) may predict adverse obstetric events in patients with systemic lupus erythematosus.
1:1-1972.
2021-01-01
-
The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients.
1:096120332098521-559.
2021-01-01
-
The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations.
1:096120332110300-12.
2021-01-01
-
The new 2019-EULAR/ACR classification criteria specific domains at diagnosis can predict damage accrual in 670 childhood-onset systemic lupus erythematosus patients.
1:096120332110543-2.
2021-01-01
-
Uric acid levels in primary antiphospholipid syndrome.
Sep:096120332110459.
2021-01-01
-
Vitamin B12 and primary antiphospholipid syndrome.
30:096120332110047-1026.
2021-01-01
-
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
1:1.
2020-01-01
-
?Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study.
1:1-1448.
2020-01-01
-
Adequate tetanus but poor diphtheria and pertussis response to a Tdap booster in adolescents with juvenile systemic lupus erythematosus.
1:096120332097326-306.
2020-01-01
-
Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
29:096120332090159-262.
2020-01-01
-
Clinical Features, Damage Accrual, and Survival in Patients With Familial Systemic Lupus Erythematosus: Data From a Multi-Ethnic, Multinational Latin American Lupus Cohort.
20:1140-1145.
2020-01-01
-
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
1:096120332094077.
2020-01-01
-
Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.
29:676-685.
2020-01-01
-
Impact of markers of endothelial injury and hypercoagulability on systemic lupus erythematosus.
29:096120331989947-190.
2020-01-01
-
Impact of markets of endothelial injury and hipercoagulability on Systemic Lupus Erythematosus.
29:182-190.
2020-01-01
-
Initial renal histology and early response predict outcomes of Brazilian lupus nephritis patients.
29:83-91.
2020-01-01
-
Lupus nephritis-related issues during COVID-19 pandemic quarantine.
1:096120332095709-1.
2020-01-01
-
Mobile health technologies for the management of systemic lupus erythematosus: a systematic review.
00:096120331989713.
2020-01-01
-
Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature.
1:096120332094966-1543.
2020-01-01
-
Physiopathology of pain in systemic erythematosus lupus.
1:096120332091987.
2020-01-01
-
Proton magnetic resonance spectroscopy ( 1 H-MRS) in rheumatic autoimmune diseases: A systematic review.
1:096120332096146-1884.
2020-01-01
-
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study.
29:096120332092840-942.
2020-01-01
-
Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.
29:1011-1020.
2020-01-01
-
Trigeminal trophic syndrome: an important simulator of discoid cutaneous lupus erythematosus - a case series.
26:096120332093516.
2020-01-01
-
Understanding the dynamics of hydroxychloroquine blood levels in lupus nephritis.
.:096120332091283-568.
2020-01-01
tem uma área de assunto
publisher
is open access
-
False
invalid format
is in DOAJ
-
False
invalid format
Metrics
2 year mean citedness
H index
i10 index
Identidade
ISSN-L
openalex identifier
-
https://openalex.org/S115920904
International Standard Serial Number (ISSN)